Last $3.59 HKD
Change Today 0.00 / 0.00%
Volume 3.0M
570 On Other Exchanges
Symbol
Exchange
Berlin
As of 3:56 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

china traditional chinese me (570) Snapshot

Open
$3.59
Previous Close
$3.59
Day High
$3.60
Day Low
$3.55
52 Week High
05/30/13 - $5.04
52 Week Low
09/5/13 - $2.66
Market Cap
9.1B
Average Volume 10 Days
2.4M
EPS TTM
$0.10
Shares Outstanding
2.5B
EX-Date
05/15/14
P/E TM
37.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA TRADITIONAL CHINESE ME (570)

Related News

No related news articles were found.

china traditional chinese me (570) Related Businessweek News

No Related Businessweek News Found

china traditional chinese me (570) Details

China Traditional Chinese Medicine Co. Limited, an investment holding company, researches and develops, produces, and sells Chinese medicine and pharmaceutical products in the People's Republic of China. The company provides traditional Chinese medicines and chemical Chinese medicines, granules, tablets, capsules, medical wine, antibiotics, and oncology powder for injection. It also engages in the extraction of Chinese medicine, preparation of modern Chinese medicine, sustained or controlled release preparation, and manufacture of traditional pills. The company offers its products under the Dezhong, Feng Liao Xing, Shengtongping, and Gaode brand names. It sells its products to hospitals and retail pharmacies. The company was formerly known as Winteam Pharmaceutical Group Limited and changed its name to China Traditional Chinese Medicine Co. Limited in November 2013. The company is based in Central, Hong Kong, and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange. As of February 28, 2013, China Traditional Chinese Medicine Co. Limited operates as a subsidiary of Fortune Hong Kong Trading Limited.

6,719 Employees
Last Reported Date: 03/23/14

china traditional chinese me (570) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: $1.9M
Compensation as of Fiscal Year 2012.

china traditional chinese me (570) Key Developments

China Traditional Chinese Medicine Co. Limited Announces Proposed Adoption of New Articles of Association

The board of directors of China Traditional Chinese Medicine Co. Limited announced that the following major statutory changes (collectively, the "Statutory Changes") which came into operation on 3 March 2014 may have impact on the provisions contained in the articles of association of the Company (the "Articles"): (a) the new Companies Ordinance, Chapter 622 of the laws of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") (the "New Companies Ordinance") has replaced the old Companies Ordinance, and the major changes include, inter alia, abolishing the par value for shares, abolishing the memorandum of association and regarding conditions in the memorandum of association of existing companies as provisions of the articles of association, removing the power to issue warrants to bearer, removing the power to convert shares into stock, requiring the company to give reasons for declining to register a transfer of shares upon request, reducing the threshold for demanding a poll, making the keeping and use of a common seal optional, and deeming consent from members to receive corporate communications via the company's website; and (b) the old Companies Ordinance has been retitled as Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the laws of Hong Kong) which retains the provisions dealing with company winding-up and insolvency, disqualification of directors as well as prospectus related matters. In order to bring the Articles in line with the Statutory Changes, the Board proposes to make amendments to the existing Articles including, the following: (1) inserting provisions in the former memorandum of association of the Company (the "Memorandum") regarding company name and members' limited liabilities into the Articles (those provisions in the Memorandum having been statutorily regarded as provisions of the Articles pursuant to section 98 of the New Companies Ordinance); (2) not having objects clause provisions in the Articles but giving the Company the capacity, rights, powers and privileges of a natural person of full age; (3) amending the definition of "Companies Ordinance" to make reference to the New Companies Ordinance and where appropriate, to make references to the Companies (Winding up and Miscellaneous Provisions) Ordinance (Chapter 32 of the laws of Hong Kong) and deleting, adding or modifying certain definitions as appropriate; (4) amending the provisions relating to various ways to alter the Company's capital in light of the abolishment of the par value for shares; (5) deleting references relating to "memorandum", "authorised share capital", "nominal value", "par value", "nominal amount of the shares", "premium", "share premium account" and "capital redemption reserve fund" or similar wordings in the existing Articles and where applicable, replacing references to nominal value of shares with total voting rights; (6) broadening the disclosure of interest by directors of the Company ("Directors") to include the disclosure of interest of the Directors' "connected entity" (within the meaning given under section 486 of the New Companies Ordinance); (7) requiring the Board to give reasons for declining to register a share transfer if requested by the transferor or transferee; (8) allowing any document signed by any two Directors or any one Director and the secretary of the Company and expressed to be executed by the Company to have the effect as if such document had been executed under the Company's common seal; (9) removing the Company's power to convert any paid up shares into stock (or vice versa); (10) reducing the threshold for demanding a poll such that shareholders of the Company ("Shareholders") holding at least 5% (instead of one-tenth) of the total voting rights of all the Shareholders having the right to vote at the meeting can demand a poll; and (11) removing the Company's power to issue warrants to bearer. The Board also proposes to make certain housekeeping amendments to the existing Articles at the same time for the purpose of bringing the Articles in line with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and improving on the drafting and to correct typographical errors. In view of the amount of amendments proposed to be made to the existing Articles, the Board proposes that the New Articles (with all proposed amendments to the existing Articles incorporated) be adopted to replace the existing Articles. The proposed adoption of the New Articles is subject to the approval of the Shareholders by way of a special resolution at the annual general meeting of the Company to be held on 5 June 2014 (the "Annual General Meeting").

China Traditional Chinese Medicine Co. Limited Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2013

China Traditional Chinese Medicine Co. Limited announced audited consolidated earnings results for the year ended December 31, 2013. For the period, the company reported turnover was RMB 1,394.6 million against RMB 1,031.77 million a year ago. Profit from operations was RMB 272.76 million against RMB 235.79 million a year ago. Profit before taxation was RMB 237.57 million against RMB 216.41 million a year ago. Profit attributable to equity shareholders of the company was RMB 198.46 million against RMB 168.53 million a year ago. Basic and diluted earnings per share were 9.68 cents against 9.45 cents a year ago. Adjusted EBITDA was RMB 380.82 million against RMB 274.17 million a year ago. The growth of turnover was attributable to a combination of factors, including optimization of product mix and a new pricing policy being implemented to some products.

China Traditional Chinese Medicine Co. Limited(SEHK:570) added to Hang Seng Composite Index

China Traditional Chinese Medicine Co. Limited will be added to the Hang Seng Composite Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
570:HK $3.59 HKD 0.00

570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 570.
View Industry Companies
 

Industry Analysis

570

Industry Average

Valuation 570 Industry Range
Price/Earnings 28.8x
Price/Sales 4.6x
Price/Book 2.6x
Price/Cash Flow 35.6x
TEV/Sales 3.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA TRADITIONAL CHINESE ME, please visit www.winteamgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.